Long-term Real-world Efficacy and Safety of Baricitinib in Alopecia Areata, Totalis, and Universalis: A Retrospective Single‑center Cohort of 330 Patients with Trichoscopy Monitoring

Published: 18 June 2026| Version 3 | DOI: 10.17632/pncfgv27c5.3
Contributors:
,
,

Description

Baricitinib in Alopecia Areata, Totalis, and Universalis

Files

Institutions

Categories

Alopecia Areata, Real-World Knowledge

Licence